ALLO - Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2021 Results - Earnings Call Transcript

Allogene Therapeutics, Inc. (ALLO) Q3 2021 Earnings Conference Call November 04, 2021 5:00 PM ET Company Participants Christine Cassiano – Chief Communications Officer David Chang – President and Chief Executive Officer Rafael Amado – Executive Vice President of Research and Development and Chief Medical Officer Eric Schmidt – Chief Financial Officer Conference Call Participants Tyler Van Buren – Cowen Michael Schmidt – Guggenheim John Newman – Canaccord Luca Issi – RBC Capital Salveen Richter – Goldman Sachs Cory Kasimov – JPMorgan Raju Prasad – William Blair Mark Breidenbach – Oppenheimer Reni Benjamin – JMP Securities Asthika Goonewardene – Truist Securities Dane Leone – Raymond James Kalpit Patel – B. Riley David Dai – SMBC Presentation Operator Hello, thank you for standing by, and welcome to Allogene Therapeutics Third Quarter 2021 Conference Call. At this time, all participant lines are in a listen-only mode. After the speakers' presentation, there will be

For further details see:

Allogene Therapeutics' (ALLO) CEO David Chang on Q3 2021 Results - Earnings Call Transcript